RE:RE:RE:I'm staring to believe the rumours for one reason.
No company has a choice. Under IFRS impairment has to be tested when there is a trigger, in this case the future price curve has not moved back up so its not a temporary thing. As such, companies had to do an impairment test in Q3 and if future cash flows based on the new curve indicated impairment, they had to take it.